Actinium Pharmaceuticals, Inc. (AMEX:ATNM) filed a Form 8-K with the Securities and Exchange Commission on February 13, 2026, disclosing a material event.
Actinium Pharmaceuticals, Inc.'s stock currently trades at $1.11 with a market capitalization of $45.5M. The Healthcare company's stock moved following the disclosure.
